FMCG supplier Supreme PLC has delivered a solid performance in the first half of FY2026, with growth across key categories and a major contribution from newly acquired brands helping drive stronger sales.
Revenue for the six months to 30 September 2025 rose 17 per cent to £132.6m, with £15.4m of that uplift coming from the additions of Clearly Drinks, Typhoo and carpet care brand 1001. The remaining £4.2m was generated organically from Supreme’s core categories. Gross profit increased 13 per cent to £38.4m.
Vaping was once again a highlight, with the company reporting a 13 per cent increase to £76.9m following a smooth transition from disposable vapes to pod systems. Supreme said all key listings were maintained throughout the shift.
Gross margin as a percentage of sales reduced marginally from 33 per cent to 31 per cent owing to the reduced margins on pod systems versus their disposable counterparts. Sales across the remainder of the category have been solid, benefitting from additional price increases and further ongoing traction from its B2C online channel.
Supreme also introduced new third-party brands during the period, which include IVG and Hayati, now distributed alongside established brands, such as Lost Mary and ElfBar.
Outside vaping, the company noted continuing pressure in its Electricals & Household category due to wider market softness, though progress in Drinks & Wellness and significant new brand integrations are expected to support second-half performance. Notably, Typhoo Tea is now fully integrated, with a turnaround plan underway including a UK manufacturing relaunch and brand refresh.
Supreme also acquired SlimFast UK & Europe shortly after the period closed – a move aimed at expanding its presence in weight management and functional wellness, categories with strong potential in convenience. Together with the 1001 purchase in September, the two deals add around £30m of annualised revenue.
Sandy Chadha, chief executive, said the company is now home to over 40 brands and licences, and continues to broaden its wellness and FMCG footprint alongside vape.
“This unique market reach will continue to enable the business to further leverage our growing product portfolio, alongside developing new products to further expand our market share,” he added.
The group is on track to deliver half of its annualised revenues from non-vape activities going forward.
Supreme expects full-year trading to be in line with market forecasts of £245m revenue and £37m adjusted EBITDA.